Author:
DE LAET L.,SCHELLEN M.,DEPYPERE M.,MARTINY D.,HALLIN M.,DE HAES P.
Abstract
“Panton-Valentine leukocidin”- producing Staphylococcus aureus is an important pathogen of purulent skin and soft-tissue infections
Staphylococcus aureus (S. aureus) colonises the skin, nose or throat in 20% to 30% of the adult population and is the most common pathogen causing mild to moderate skin infections. Panton-Valentine leukocidin (PVL) is an important virulence factor for S. aureus and plays a potential role in the pathogenesis of dermal necrosis.
PVL is strongly associated with recurrent purulent skin infections and frequent need for surgical drainage. It is comparatively less common in colonisation and invasive infections (such as pneumonia, musculoskeletal disease and bacteraemia).
The number of community-acquired PVLP-SA clones in Belgium remains stable since 2014. PVL-toxin detection in Belgium is limited to the National Reference Centre for S. aureus (LHUB-ULB, Brussels). Because of the limited indications for toxin testing and lack of impact on antibiotic therapy, there is currently no need for PVL-toxin detection outside the reference laboratory.
On the other hand, increased awareness can lead to more efficient and systematic decolonisation policies and thereby reduce the risk of recurrent skin infections or outbreaks in (healthcare) institutions.
In this case report followed by a literature review, we would like to inform all interested and involved clinicians (general practitioners, dermatologists, internists, paediatricians) about the national guidelines for PVL-toxin detection and the associated approach.
Reference16 articles.
1. 1. Agentschap Zorg en Gezondheid. Richtlijn infectieziektebestrijding Vlaanderen – Staphylococcus Aureus-infecties, inclusief MRSA. Beschikbaar via: https://www.zorg-en-gezondheid.be/sites/default/files/atoms/files/Staphylococcus%20aureus_2017_NH.pdf
2. 2. Robinson DA, Kearns AM, Holmes A et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired methicillin-resistant clone. Lancet 2005; 365: 1256-1258.
3. 3. Saeed K, Gould I, Esposito S et al. Panton–Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy. International Journal of Antimicrobial Agents 2018; 51: 16-25.
4. 4. L. Shallcross, Fragaszy E, Johnson AM, Hayward AC. The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2013; 13: 43-54.
5. 5. Brown ML, O´Hara FP, Close NM et al. Prevalence and sequence variation of Panton-Valentine leukocidin in methicillin-resistant and methicillin-susceptible staphylococcus aureus strains in the United States. J Clin Microbiol 2012; 50: 86-90.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献